CVS Health CorporationCVS
Close of Friday, October 23, 2026 · CVS Health Corporation is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$93.47
vs its Pivot
+5.6%
OnlyAlpha Score
69
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +9.9% | +20.5% | +17.6% | +13.8% | +5.1% |
Dividend: $2.66 a share over the last 12 months, a 2.85% yield at today's price.
Who runs and owns it
In these funds
Big investors that own it (latest 13F)
| Viking Global | 1.1% of holdings |
| Point72 | 0.3% of holdings |
| Citadel | 0.3% of holdings |
Suppliers, customers and partners
Sells to CVS
| Cardinal Health | 28% of revenue |
| McKesson | ~24% of revenue |
| United Therapeutics | CVS Specialty; Tyvaso via spec. distributors 59% of rev |
| Amneal Pharmaceuticals | top-4 customers; ~71% of net revenue combined |
CVS sells to
| U.S. Government | ~20% of revenue (HCB federal; ~79% of it CMS Medicare) |
Partners and deals
| Cardinal Health | Red Oak Sourcing (50/50) |
| Target | pharmacies within Target stores |
From the companies' own annual reports filed with the SEC.
Healthcare · Health insurers and PBMs
Get CVS in your free daily emailAfter every close: whether CVS is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track CVS free → Full Stock check
Track CVS free → Full Stock check